Hood River Capital Management LLC Vaxcyte, Inc. Transaction History
Hood River Capital Management LLC
- $5.79 Billion
- Q4 2024
A detailed history of Hood River Capital Management LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Hood River Capital Management LLC holds 401,442 shares of PCVX stock, worth $33.1 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
401,442Holding current value
$33.1 Million% of portfolio
0.57%Shares
1 transactions
Others Institutions Holding PCVX
# of Institutions
346Shares Held
130MCall Options Held
534KPut Options Held
248K-
Vanguard Group Inc Valley Forge, PA12MShares$986 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$872 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$820 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$717 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$512 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.89B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...